H.R. 5074 · 118th Congress

Kidney PATIENT Act of 2023

Introduced on Jul 28, 2023 by Earl L. "Buddy" Carter (R-GA-1). 45 cosponsors, 33 of them from another party. Latest action (Jun 11, 2024): Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-548, Part I.

Stage
Reported by committee
Introduced
Jul 28, 2023
Cosponsors
45
33 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To amend the American Taxpayer Relief Act of 2012 to delay implementation of the inclusion of oral-only ESRD-related drugs in the Medicare ESRD prospective payment system.

Subjects

  • Digestive and metabolic diseases
  • Health care costs and insurance
  • Medicare
  • Prescription drugs

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Earl L. "Buddy" CarterR-GA-1Sponsor

Democrats · 33

Republicans · 12

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Jul 28, 2023Introduced in House
  2. Jul 28, 2023Introduced in House
  3. Jul 28, 2023 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Jul 28, 2023 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. Aug 4, 2023 · HouseReferred to the Subcommittee on Health.
  6. Mar 6, 2024 · HouseCommittee Consideration and Mark-up Session Held
  7. Mar 6, 2024 · HouseCommittee Consideration and Mark-up Session Held
  8. Mar 6, 2024 · HouseOrdered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 1.
  9. Mar 12, 2024 · HouseSubcommittee Consideration and Mark-up Session Held
  10. Mar 12, 2024 · HouseForwarded by Subcommittee to Full Committee by the Yeas and Nays: 16 - 10.
  11. Mar 20, 2024 · HouseCommittee Consideration and Mark-up Session Held
  12. Mar 20, 2024 · HouseOrdered to be Reported (Amended) by the Yeas and Nays: 37 - 10.
  13. Jun 11, 2024Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-548, Part I.
  14. Jun 11, 2024 · HouseReported (Amended) by the Committee on Ways and Means. H. Rept. 118-548, Part I.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. ARDELYX, INC.25 reports
    $4.1M reported (all issues)
  2. Fresenius Medical Care North America15 reports
    $8.3M reported (all issues)
  3. Kidney Care Partners10 reports
    $510K reported (all issues)
  4. AT&T Services, Inc.6 reports
    Federal contractor: AT&T TECHNICAL SERVICES COMPANY, INC$10.2M in contracts, FY2026AI match · 94%
  5. DAVITA INC.6 reports
    $3.2M reported (all issues)Federal contractor: DAVITA INC.$179.4M in contracts, FY2026AI match · 97%
  6. AKEBIA THERAPEUTICS INC.5 reports
    $1.4M reported (all issues)
  7. American Nephrology Nurses Association5 reports
    $150K reported (all issues)
  8. Dialysis Clinic, Inc.5 reports
    $100K reported (all issues)Federal contractor: DIALYSIS CLINIC, INC.$17.4M in contracts, FY2026AI match · 95%
  9. NATIONAL KIDNEY FOUNDATION5 reports
    $605K reported (all issues)Federal contractor: NATIONAL KIDNEY FOUNDATION, INCAI match · 100%
  10. National Minority Quality Forum Action Network5 reports
    $240K reported (all issues)
  11. Nonprofit Kidney Care Alliance5 reports
    $450K reported (all issues)
  12. Renal Healthcare Association5 reports
    $350K reported (all issues)
  13. American Society of Nephrology4 reports
    $320K reported (all issues)Federal contractor: AMERICAN SOCIETY OF NEPHROLOGY INCAI match · 100%
  14. The Rogosin Institute4 reports
    $120K reported (all issues)Federal contractor: THE ROGOSIN INSTITUTE INC$297.5K in contracts, FY2026AI match · 100%
  15. American Kidney Fund3 reports
    $565K reported (all issues)
  16. CorMedix Inc.3 reports
    $540K reported (all issues)
  17. The Kidney Care Council3 reports
    $225K reported (all issues)
  18. Vifor International AG (CSL Vifor)3 reports
    $120K reported (all issues)
  19. Dialysis Patient Citizens2 reports
    $800K reported (all issues)
  20. Sanofi U.S. Services, Inc.2 reports
    $100K reported (all issues)
  21. U.S. RENAL CARE2 reports
    $100K reported (all issues)Federal contractor: US RENAL CARE INC$26.9M in contracts, FY2026AI match · 100%
  22. Alliance for Aging Research1 report
  23. NATIONAL COMMUNITY PHARMACISTS ASSOCIATION1 report
    $412K reported (all issues)Federal contractor: NATIONAL COMMUNITY PHARMACISTS ASSOCIATIONAI match · 100%
  24. Vifor Fresenius Medical Care Renal Pharma AG1 report
    $50K reported (all issues)
  25. Vifor Fresenius Medical Care Renal Pharma AG (fka Vifor Intl AG (CSL Vifor)1 report
    $50K reported (all issues)

Reports filed in 2023, 2024, 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.